Inventor
ANDERSON DAVID C
US45 patents
⚠️ This page may combine multiple inventors who share the name “ANDERSON DAVID C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RIGEL PHARMACEUTICALS INC
12 patentsUS6979549B2Dec 27, 2005
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a CLLD8 protein
RIGEL PHARMACEUTICALS INC5 citations73
US7425418B2Sep 16, 2008
Compounds that modulate processes associated with IgE production
RIGEL PHARMACEUTICALS INC3 citations62
US7378251B2May 27, 2008
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa protein
RIGEL PHARMACEUTICALS INC2 citations62
US7604951B2Oct 20, 2009
Method for identifying compounds that modulate RXR associated processes with IgE production
RIGEL PHARMACEUTICALS INC1 citations51
US7598050B2Oct 6, 2009
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein
RIGEL PHARMACEUTICALS INC1 citations51
US7563585B2Jul 21, 2009
Methods of assaying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa protein (TXNL)
RIGEL PHARMACEUTICALS INC0 citations51
US7422867B2Sep 9, 2008
Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein
RIGEL PHARMACEUTICALS INC0 citations51
US7374894B2May 20, 2008
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein
RIGEL PHARMACEUTICALS INC0 citations51
US7241581B2Jul 10, 2007
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a c-MYC protein
RIGEL PHARMACEUTICALS INC0 citations51
US7208289B2Apr 24, 2007
Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein
RIGEL PHARMACEUTICALS INC0 citations51
US7189523B2Mar 13, 2007
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a B-cell associated protein
RIGEL PHARMACEUTICALS INC0 citations51
US7141434B2Nov 28, 2006
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing an adenosine kinase
RIGEL PHARMACEUTICALS INC0 citations51
SOMATOGEN INC
10 patentsUS5679777AOct 21, 1997
Hemoglobins as drug delivery agents
SOMATOGEN INC100 citations97
US5599907AFeb 4, 1997
Production and use of multimeric hemoglobins
SOMATOGEN INC99 citations97
US5844089ADec 1, 1998
Genetically fused globin-like polypeptides having hemoglobin-like activity
SOMATOGEN INC52 citations95
US5844088ADec 1, 1998
Hemoglobin-like protein comprising genetically fused globin-like polypeptides
SOMATOGEN INC18 citations92
US5739011AApr 14, 1998
DNA for the production of multimeric hemoglobins
SOMATOGEN INC18 citations92
US5801019ASep 1, 1998
DNA encoding fused alpha-beta globin pseuodimer and production of pseudotetrameric hemoglobin
SOMATOGEN INC9 citations81
US5759517AJun 2, 1998
Hemoglobins as drug delivery agents
SOMATOGEN INC14 citations73
US5744329AApr 28, 1998
DNA encoding fused di-beta globins and production of pseudotetrameric hemoglobin
SOMATOGEN INC7 citations73
US5844090ADec 1, 1998
Modified hemoglobin-like compounds
SOMATOGEN INC16 citations70
US5717058AFeb 10, 1998
Peptide inhibitors of tax-dependent transcription
SOMATOGEN INC11 citations70
NEORX CORP
6 patentsUS5169933ADec 8, 1992
Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
NEORX CORP409 citations98
US5106951AApr 21, 1992
Antibody conjugates
NEORX CORP133 citations98
US5252713AOct 12, 1993
Polymeric carriers for non-covalent drug conjugation
NEORX CORP121 citations97
US4986979AJan 22, 1991
Imaging tissue sites of inflammation
NEORX CORP94 citations96
US5171563ADec 15, 1992
Cleavable linkers for the reduction of non-target organ retention of immunoconjugates
NEORX CORP44 citations93
US5135736AAug 4, 1992
Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
NEORX CORP98 citations93
UT BATTELLE LLC
4 patentsUS11538597B2Dec 27, 2022
Additive manufacturing of composite neutron absorbing components
UT BATTELLE LLC2 citations63
US11898226B2Feb 13, 2024
Additive manufacturing process for producing aluminum-boron carbide metal matrix composites
UT BATTELLE LLC0 citations60
US12062464B2Aug 13, 2024
Method for producing neutron collimators using additive manufacturing
UT BATTELLE LLC0 citations56
US11404180B2Aug 2, 2022
Method for producing collimators and other components from neutron absorbing materials using additive manufacturing
UT BATTELLE LLC1 citations56
(unassigned)
3 patentsAMGEN INC
3 patentsUS6800732B2Oct 5, 2004
Human collagenase inhibitor, recombinant vector system for using same and recombinant DNA method for the manufacture of same
AMGEN INC3 citations59
US6342374B1Jan 29, 2002
Human collagenase inhibitor, recombinant vector system for using same and recombinant-DNA method for the manufacture of same
AMGEN INC1 citations59
US6090585AJul 18, 2000
Human collagenase inhibitor sequence, recombinant vector system for using same and recombinant-DNA method for the manufacture of same
AMGEN INC1 citations48